Cycles of Dose-Intensive Chemotherapy with Peripheral Stem Cell Support in Persistent or Recurrent Platinum-Sensitive Ovarian Cancer

By Morgan M.A.   Stadtmauer E.A.   Luger S.M.   Porter D.L.   Mangan P.A.   O'neil P.   Kamelle S.   Benjamin I.   Mick R.   King S.A.   Rubin S.C.  

Gynecologic Oncology, Vol. 67, Iss. 3, 1997-12 ,pp. : 272-276

Elsevier

Access to resources Recommend Favorite

Paclitaxel-Anthracycline Combination Chemotherapy in Relapsing Advanced Ovarian Cancer after Platinum-Based Chemotherapy: A Pilot Study

By Kurtz J.E.   Deplanque G.   Duclos B.   Eichler F.   Giron C.   Limacher J.M.   Herbrecht R.   Maloisel F.   Oberling F.   Bergerat J.P.   Dufour P.  

Gynecologic Oncology, Vol. 70, Iss. 3, 1998-09 ,pp. : 414-417

Elsevier

Access to resources Recommend Favorite

Taxol as Second-Line Treatment in Patients with Advanced Ovarian Cancer after Platinum-Based First-Line Chemotherapy

By Mayerhofer K.   Kucera E.   Zeisler H.   Speiser P.   Reinthaller A.   Sevelda P.  

Gynecologic Oncology, Vol. 64, Iss. 1, 1997-01 ,pp. : 109-113

Elsevier

Access to resources Recommend Favorite

Prognostic implications of survivin and lung resistance protein in advanced non-small cell lung cancer treated with platinum-based chemotherapy

By                      

Oncology Letters, Vol. 11, Iss. 1, 2016-01 ,pp. : 723-730

Spandidos Publications

Access to resources Recommend Favorite

Predicting toxicity in advanced lung cancer patients treated with platinum-based chemotherapy

By Ioannidis Georgios   Souglakos John   Georgoulias Vassilis  

Lung Cancer Management, Vol. 2, Iss. 4, 2013-08 ,pp. : 281-293

Future Medicine

Access to resources Recommend Favorite